Lee, Boram

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC

Kim, Y., Lee, B., Shim, J. H., Lee, S.-H., Park, W.-Y., Choi, Y.-L., Sun, J.-M., Ahn, J. S., Ahn, M.-J., & Park, K. (2019) · Journal of Thoracic Oncology

Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics

Cited by 174

Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers

Lee, B., Lee, T., Lee, S.-H., Choi, Y.-L., & Han, J. (2016) · Oncotarget

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 78

Clinical protein science in translational medicine targeting malignant melanoma

Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., et al. (2019) · Cell Biology and Toxicology

Melanoma and MAPK PathwaysAdvanced Proteomics Techniques and Applications

Cited by 45

A biobanking turning-point in the use of formalin-fixed, paraffin tumor blocks to unveil kinase signaling in melanoma

Velasquez, E., Szadai, L., Zhou, Q., Kim, Y., Pla, I., Sanchez, A., Appelqvist, R., Oskolas, H., Marko‐Varga, M., Lee, B., et al. (2021) · Clinical and Translational Medicine

Advanced Proteomics Techniques and ApplicationsMelanoma and MAPK Pathways

Cited by 13